State Street Corp Atea Pharmaceuticals, Inc. Transaction History

State Street Corp

$2.21 Trillion
Q1 2024

A detailed history of State Street Corp transactions in Atea Pharmaceuticals, Inc. stock. As of the latest transaction made, State Street Corp holds 1,678,383 shares of AVIR stock, worth $6.16 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,678,383

Previous 1,630,037 2.97%

Holding current value

$6.16 Million

Previous $4.97 Million 36.39%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$3.09 - $4.56 $149,389 - $220,457	48,346 Added 2.97%	1,678,383 $6.78 Million
Q4 2023 Feb 14, 2024	BUY	$2.8 - $3.35 $346,640 - $414,730	123,800 Added 8.22%	1,630,037 $4.97 Million
Q3 2023 Nov 14, 2023	SELL	$3.0 - $3.79 $81,153 - $102,523	-27,051 Reduced 1.76%	1,506,237 $4.52 Million
Q2 2023 Aug 14, 2023	SELL	$3.21 - $5.06 $1.06 Million - $1.67 Million	-330,049 Reduced 17.71%	1,533,288 $5.73 Million
Q1 2023 May 15, 2023	SELL	$3.0 - $4.97 $223,179 - $369,733	-74,393 Reduced 3.84%	1,863,337 $6.24 Million

Q4 2022 Feb 14, 2023	BUY	$4.35 - $6.17 $187,023 - $265,272	42,994 Added 2.27%	1,937,730 $9.32 Million
Q3 2022 Nov 15, 2022	BUY	$5.49 - $8.79 $501,610 - $803,124	91,368 Added 5.07%	1,894,736 $10.8 Million
Q2 2022 Aug 15, 2022	SELL	$5.33 - $8.18 $366,202 - $562,015	-68,706 Reduced 3.67%	1,803,368 $12.8 Million
Q1 2022 May 16, 2022	SELL	$5.5 - $9.19 $2.49 Million - $4.17 Million	-453,379 Reduced 19.5%	1,872,074 $13.5 Million
Q4 2021 Feb 14, 2022	BUY	$7.67 - $44.59 $9.38 Million - $54.5 Million	1,222,601 Added 110.86%	2,325,453 $20.8 Million
Q3 2021 Nov 15, 2021	BUY	$21.33 - $35.06 $3.01 Million - $4.95 Million	141,085 Added 14.67%	1,102,852 $38.7 Million
Q2 2021 Aug 16, 2021	BUY	$19.22 - $59.08 $13 Million - $40 Million	677,244 Added 238.03%	961,767 $20.7 Million
Q1 2021 May 17, 2021	BUY	$41.42 - $88.44 $2.56 Million - $5.47 Million	61,849 Added 27.78%	284,523 $17.6 Million
Q4 2020 Feb 16, 2021	BUY	$26.36 - $41.78 $5.87 Million - $9.3 Million	222,674 New	222,674 $9.3 Million

Others Institutions Holding AVIR

# of Institutions

119

Shares Held

49.6M

Call Options Held

108K

Put Options Held

327K

View Full List

About Atea Pharmaceuticals, Inc.

Ticker AVIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,258,600
Market Cap $306M
Description
Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, an antiviral drug candidate that is in Phase II clinical trial for the treatment of patients with COVID-19. The ...

More about AVIR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Atea Pharmaceuticals, Inc. Transaction History